Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study (Advances in Therapy, (2020), 37, 4, (1436-1451), 10.1007/s12325-020-01239-8)

The VISIONARY Study Group

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original article, the The VISIONARY Study Group Principal Investigator Jose Javier Garcia-Medina.

Original languageEnglish
Pages (from-to)3643-3644
Number of pages2
JournalAdvances in Therapy
Volume37
Issue number8
DOIs
Publication statusPublished - Aug 1 2020

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study (Advances in Therapy, (2020), 37, 4, (1436-1451), 10.1007/s12325-020-01239-8)'. Together they form a unique fingerprint.

Cite this